Revenue grew to TRY 39.2 billion and operating profit to TRY 7.48 billion year-over-year, while net profit attributable to equity holders was TRY 4.07 billion. Major developments include the acquisition of Özel Medistanbul Hospital and significant bond issuances.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.